<p>KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer</p>
Jun Zhang(Army Medical University), Guowei Shi(Fudan University)
Cited by 62
Related Papers
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
|The Lancet Respiratory Medicine|2022|140
USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
|Journal of Experimental & Clinical Cancer Research|2021|70
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|70
The role of MAP2 kinases and p38 kinase in acute murine liver injury models
|Cell Death and Disease|2017|65
Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells
|Cancer Biomarkers|2018|39